These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 646989)

  • 21. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
    Wilson CR; Sauer JM; Carlson GP; Wallin R; Ward MP; Hooser SB
    Toxicology; 2003 Aug; 189(3):191-8. PubMed ID: 12832152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies of prothrombin biosynthesis in cell-free systems. 3. Regulation by vitamin K and warfarin of prothrombin biosynthesis in rat liver microsomes.
    Johnston MF; Olson RE
    J Biol Chem; 1972 Jun; 247(12):4001-7. PubMed ID: 5033399
    [No Abstract]   [Full Text] [Related]  

  • 23. Vitamin K epoxide reductase activity and its inhibition by warfarin in young and old rats.
    Hallak HO; Wedlund PJ
    Drug Metab Dispos; 1991; 19(1):278-9. PubMed ID: 1673414
    [No Abstract]   [Full Text] [Related]  

  • 24. Vitamin K epoxidase activity of rough and smooth microsomes from rat liver.
    Egeberg K; Helgeland L
    Biochim Biophys Acta; 1980 Feb; 627(3):225-9. PubMed ID: 7353054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The characterization of potent novel warfarin analogs.
    Kerr JS; Li HY; Wexler RS; Robinson AJ; Robinson CS; Boswell GA; Krauthauser C; Harlow PP
    Thromb Res; 1997 Oct; 88(2):127-36. PubMed ID: 9361366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anticoagulant activity.
    Thijssen HH; Baars LG; Vervoort-Peters HT
    Br J Pharmacol; 1988 Nov; 95(3):675-82. PubMed ID: 3207986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conversion of vitamin K epoxide to hydroxyvitamin K by liver microsomes from warfarin-resistant rats.
    Nutr Rev; 1983 Aug; 41(8):253-4. PubMed ID: 6355923
    [No Abstract]   [Full Text] [Related]  

  • 28. B16 tumor cells contain a warfarin sensitive vitamin K1 2,3 epoxide reductase.
    Uitendaal MP; Thijssen HH; Drittij-Reijnders MJ; Hoeijmakers MJ
    Biochem Biophys Res Commun; 1986 Jun; 137(3):1015-20. PubMed ID: 3729947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin K-dependent carboxylase. Stoichiometry of carboxylation and vitamin K 2,3-epoxide formation.
    Larson AE; Friedman PA; Suttie JW
    J Biol Chem; 1981 Nov; 256(21):11032-5. PubMed ID: 7287748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulfaquinoxaline inhibition of vitamin K epoxide and quinone reductase.
    Preusch PC; Hazelett SE; Lemasters KK
    Arch Biochem Biophys; 1989 Feb; 269(1):18-24. PubMed ID: 2916837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin K-dependent carboxylase: increased activity in a hypoprothrombinemia state.
    Shah DV; Suttie JW
    Arch Biochem Biophys; 1978 Dec; 191(2):571-7. PubMed ID: 742892
    [No Abstract]   [Full Text] [Related]  

  • 32. Depression of liver microsomal vitamin K epoxide reductase activity associated with antibiotic-induced coagulopathy.
    Matsubara T; Touchi A; Harauchi T; Takano K; Yoshizaki T
    Biochem Pharmacol; 1989 Aug; 38(16):2693-701. PubMed ID: 2764989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Warfarin poisoning and vitamin K antagonism in rat and human liver. Design of a system in vitro that mimics the situation in vivo.
    Wallin R; Martin LF
    Biochem J; 1987 Jan; 241(2):389-96. PubMed ID: 3593198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction.
    Lee JJ; Principe LM; Fasco MJ
    Biochemistry; 1985 Dec; 24(25):7063-70. PubMed ID: 4084561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin K-dependent carboxylase: possible artifact of analysis due to a pyridine nucleotide-dependent carboxylation.
    Wallin R; Suttie JW
    Biochem Biophys Res Commun; 1980 Jun; 94(4):1374-80. PubMed ID: 7396966
    [No Abstract]   [Full Text] [Related]  

  • 36. R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat.
    Fasco MJ; Principe LM
    J Biol Chem; 1982 May; 257(9):4894-901. PubMed ID: 7068669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Responses of renal and hepatic vitamin K dependent gamma-glutamyl carboxylase substrates to warfarin and vitamin K treatments.
    Karl PI; Friedman PA
    Int J Biochem; 1985; 17(12):1313-6. PubMed ID: 4092815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Warfarin resistance in a Chicago strain of rats.
    Misenheimer TM; Suttie JW
    Biochem Pharmacol; 1990 Nov; 40(9):2079-84. PubMed ID: 2242035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin K-dependent carboxylase. Requirements of the rat liver microsomal enzyme system.
    Sadowski JA; Esmon CT; Suttie JW
    J Biol Chem; 1976 May; 251(9):2770-6. PubMed ID: 177420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolism and properties of a liver precursor to prothrombin.
    Suttie JW
    Vitam Horm; 1974; 32():463-81. PubMed ID: 4617405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.